These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 15106294)

  • 1. Search for poliovirus carriers among people with primary immune deficiency diseases in the United States, Mexico, Brazil, and the United Kingdom.
    Halsey NA; Pinto J; Espinosa-Rosales F; Faure-Fontenla MA; da Silva E; Khan AJ; Webster AD; Minor P; Dunn G; Asturias E; Hussain H; Pallansch MA; Kew OM; Winkelstein J; Sutter R;
    Bull World Health Organ; 2004 Jan; 82(1):3-8. PubMed ID: 15106294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of prolonged and chronic poliovirus excretion among persons with primary immune deficiency disorders in Sri Lanka.
    de Silva R; Gunasena S; Ratnayake D; Wickremesinghe GD; Kumarasiri CD; Pushpakumara BA; Deshpande J; Kahn AL; Sutter RW
    Vaccine; 2012 Dec; 30(52):7561-5. PubMed ID: 23099333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for long-term poliovirus excretion among children with primary immunodeficiency disorders: preparation for the polio posteradication era in Bangladesh.
    Sazzad HM; Rainey JJ; Kahn AL; Mach O; Liyanage JB; Alam AN; Kawser CA; Hossain A; Sutter R; Luby SP
    J Infect Dis; 2014 Nov; 210 Suppl 1():S373-9. PubMed ID: 25316858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poliovirus excretion following vaccination with live poliovirus vaccine in patients with primary immunodeficiency disorders: clinicians' perspectives in the endgame plan for polio eradication.
    Galal NM; Meshaal S; ElHawary R; Nasr E; Bassiouni L; Ashghar H; Farag NH; Mach O; Burns C; Iber J; Chen Q; ElMarsafy A
    BMC Res Notes; 2018 Oct; 11(1):717. PubMed ID: 30305145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poliovirus Excretion in Children with Primary Immunodeficiency Disorders, India.
    Mohanty MC; Madkaikar MR; Desai M; Taur P; Nalavade UP; Sharma DK; Gupta M; Dalvi A; Shabrish S; Kulkarni M; Aluri J; Deshpande JM
    Emerg Infect Dis; 2017 Oct; 23(10):1664-1670. PubMed ID: 28930011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of poliovirus strains from long-term excretors with primary immunodeficiencies.
    Minor P
    Dev Biol (Basel); 2001; 105():75-80. PubMed ID: 11763340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Search for poliovirus long-term excretors among patients affected by agammaglobulinemia.
    Fiore L; Plebani A; Buttinelli G; Fiore S; Donati V; Marturano J; Soresina A; Martire B; Azzari C; Nigro G; Cardinale F; Trizzino A; Pignata C; Alvisi P; Anastasio E; Bossi G; Ugazio AG
    Clin Immunol; 2004 Apr; 111(1):98-102. PubMed ID: 15093557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poliovirus excretion among persons with primary immune deficiency disorders: summary of a seven-country study series.
    Li L; Ivanova O; Driss N; Tiongco-Recto M; da Silva R; Shahmahmoodi S; Sazzad HM; Mach O; Kahn AL; Sutter RW
    J Infect Dis; 2014 Nov; 210 Suppl 1():S368-72. PubMed ID: 25316857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of vaccine-derived polioviruses in stools of immunodeficient children in South Africa.
    Pavlov DN; Van Zyl WB; Van Heerden J; Kruger M; Blignaut L; Grabow WO; Ehlers MM
    J Appl Microbiol; 2006 Dec; 101(6):1367-79. PubMed ID: 17105568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistence of vaccine-derived polioviruses among immunodeficient persons with vaccine-associated paralytic poliomyelitis.
    Khetsuriani N; Prevots DR; Quick L; Elder ME; Pallansch M; Kew O; Sutter RW
    J Infect Dis; 2003 Dec; 188(12):1845-52. PubMed ID: 14673763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccine-Derived Polioviruses and Children with Primary Immunodeficiency, Iran, 1995-2014.
    Shaghaghi M; Shahmahmoodi S; Abolhassani H; Soleyman-Jahi S; Parvaneh L; Mahmoudi S; Chavoshzadeh Z; Yazdani R; Zahraei SM; Ebrahimi M; Eslamian MH; Tabatabaie H; Yousefi M; Kandelousi YM; Oujaghlou A; Rezaei N; Aghamohammadi A
    Emerg Infect Dis; 2016 Oct; 22(10):1712-9. PubMed ID: 27648512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poliovirus excretion in Guatemalan adults and children with HIV infection and children with cancer.
    Asturias EJ; Grazioso CF; Luna-Fineman S; Torres O; Halsey NA
    Biologicals; 2006 Jun; 34(2):109-12. PubMed ID: 16682223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No evidence for prolonged excretion of polioviruses in persons with residual paralytic poliomyelitis in Ethiopia, Pakistan and Guatemala.
    Khan AJ; Gebreselassie H; Asturias EJ; Agboatwalla M; Teklehaimanot R; Luby SP; Beyene B; Chezzi C; Asghar H; Moatter T; Torres OR; Kew O; Winkelstein J; Halsey NA
    Biologicals; 2006 Jun; 34(2):113-6. PubMed ID: 16682222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccine-associated paralytic poliomyelitis. United States: 1973 through 1984.
    Nkowane BM; Wassilak SG; Orenstein WA; Bart KJ; Schonberger LB; Hinman AR; Kew OM
    JAMA; 1987 Mar; 257(10):1335-40. PubMed ID: 3029445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling the prevalence of immunodeficiency-associated long-term vaccine-derived poliovirus excretors and the potential benefits of antiviral drugs.
    Duintjer Tebbens RJ; Pallansch MA; Thompson KM
    BMC Infect Dis; 2015 Sep; 15():379. PubMed ID: 26382043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive screening for immunodeficiency-associated vaccine-derived poliovirus: an essential oral poliovirus vaccine cessation risk management strategy.
    Duintjer Tebbens RJ; Thompson KM
    Epidemiol Infect; 2017 Jan; 145(2):217-226. PubMed ID: 27760579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccine-derived poliomyelitis 12 years after infection in Minnesota.
    DeVries AS; Harper J; Murray A; Lexau C; Bahta L; Christensen J; Cebelinski E; Fuller S; Kline S; Wallace GS; Shaw JH; Burns CC; Lynfield R
    N Engl J Med; 2011 Jun; 364(24):2316-23. PubMed ID: 21675890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation of poliovirus shedding following vaccination in children with antibody deficiency disorders.
    Galal NM; Bassiouny L; Nasr E; Abdelmeguid N
    J Infect Dev Ctries; 2012 Dec; 6(12):881-5. PubMed ID: 23276742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure to clear persistent vaccine-derived neurovirulent poliovirus infection in an immunodeficient man.
    MacLennan C; Dunn G; Huissoon AP; Kumararatne DS; Martin J; O'Leary P; Thompson RA; Osman H; Wood P; Minor P; Wood DJ; Pillay D
    Lancet; 2004 May; 363(9420):1509-13. PubMed ID: 15135598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The feasibility of identifying children with primary immunodeficiency disorders: preparation for the polio post-eradication era in Bangladesh.
    Sazzad HM; Rainey JJ; Mach O; Sutter R; Diordista S; Kawser CA; Mobarak R; Alam D; Chowdhury MA; Hossain MJ; Hasan AS; Luby SP
    Vaccine; 2012 Aug; 30(36):5396-400. PubMed ID: 22728220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.